Please Wait a Moment
X

Articles

02Oct

Update on the Ortho Conversion

02 Oct, 2020 | Return|

At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.

Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications

Related

CTS Form Updates 2020

CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...

Read More >
Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...

Read More >

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

This is the first update to the original CTS communication distributed on July 6th. As previously co...

Read More >

Reminder-Bio-Rad Geenius HIV 1/2 Implemented

CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...

Read More >

October 20th Update on Ortho Conversion

The revised CTS algorithm associated with the Ortho platform is now available for review.  Clie...

Read More >

Reminder- The CTS Reentry form- CTS-00172 implements 7/2/18

Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...

Read More >